New antimicrobial strategies in cystic fibrosis.
van Westreenen
Mireille
M
Department of Medical Microbiology & Infectious Diseases, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, the Netherlands. m.vanwestreenen@erasmusmc.nl
Tiddens
Harm A W M
HA
D000280:Administration, Inhalation; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy* / Q000209:etiology; D003550:Cystic Fibrosis / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology*; D004352:Drug Resistance, Microbial; D006801:Humans; D007263:Infusions, Parenteral; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents